Skip to main content

Bayesian Capital Management, LP

SEC CIK
0001632551
Latest filing
Aug 14, 2026

CERE holding history

Cerevel Therapeutics Holdings, Inc. in every 13F filed by Bayesian Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CERE overviewAll 13F holders of CEREFull Q2 2026 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q3 2023
Holdings of CERE by Bayesian Capital Management, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−43,382−100.0%Sold outHolders
Q4 202343,382$1.84M0.2%+14,500+50.2%AddedHolders
Q3 202328,882$630.5K0.1%+28,882NewHolders